Alpine Woods Capital Investors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Alpine Woods Capital Investors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,324	Closed	-$968K	–	252
2020 Q3	$968K	Buy	18,324 +1,774	+11%	+$109K	0.15%	149
2020 Q2	$1.01M	Buy	16,550 +2,000	+14%	+$116K	0.2%	124
2020 Q1	$823K	Buy	+14,550	New	+$829K	0.18%	122

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alpine Woods Capital Investors's BSTC Position: Q4 2020 in Review

Alpine Woods Capital Investors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 18,324 shares — an estimated $968K sold.

Alpine Woods Capital Investors first reported a position in BSTC in Q1 2020 and held it in 3 quarters. The position peaked at $1.01M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Alpine Woods Capital Investors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Alpine Woods Capital Investors sold 18,324 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $968K.
Alpine Woods Capital Investors first reported a position in BioSpecifics Technologies Corp. in Q1 2020 and held it in 3 quarters.
Alpine Woods Capital Investors's BioSpecifics Technologies Corp. position peaked at $1.01M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2020, filed 1 Feb 2021.